Literature DB >> 20585940

Quantitative ultrasound and radiographic absorptiometry are associated with vertebral deformity in Japanese Women: the Hizen-Oshima study.

Y Abe1, N Takamura, Z Ye, M Tomita, M Osaki, Y Kusano, T Nakamura, K Aoyagi, S Honda.   

Abstract

UNLABELLED: We evaluated the ability of heel quantitative ultrasound (QUS) and metacarpal radiographic absorptiometry (RA) to identify subjects with vertebral deformities in Japanese women aged ≥40. Both QUS and RA were associated with vertebral deformities, and the estimated prevalence at each T-score widely varied with age.
INTRODUCTION: Heel QUS and metacarpal RA have been used for screening patients to evaluate risk of osteoporotic fractures. The aim of this study was to evaluate the ability of QUS and RA to identify women with vertebral deformities in 570 Japanese women aged ≥40, and to estimate the prevalence of vertebral deformity at each T-score.
METHODS: Calcaneal QUS and metacarpal RA were performed. Radiographic vertebral deformities were assessed by quantitative morphometry, defined as vertebral heights more than 3 SD below the normal mean.
RESULTS: The receiver operating characteristic analysis showed that both calcaneal stiffness index (SI) and metacarpal bone mineral density (BMD) were associated with vertebral deformities. Using the T-score of -2.5 as a cutoff value, the specificity and sensitivity for identifying individuals with vertebral deformities was 65% and 83% for calcaneal SI, and 40% and 88% for metacarpal BMD, respectively. The prevalence of vertebral deformity was estimated using age-adjusted logistic regression models. Women with calcaneal SI T-score of -2.5 had a 2% estimated probability of vertebral deformity at age 40, and 22% at age 80. For metacarpal BMD T-score of -2.5, estimated probability was less than 1% at age 40, and 27% at age 80.
CONCLUSION: Both calcaneal SI and metacarpal BMD were associated with prevalence of vertebral deformity. Furthermore, the prevalence widely varied with age at any given bone value.

Entities:  

Mesh:

Year:  2010        PMID: 20585940     DOI: 10.1007/s00198-010-1295-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  39 in total

1.  Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or =70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study.

Authors:  Marc-Antoine Krieg; Jacques Cornuz; Christiane Ruffieux; Guy Van Melle; Daniel Büche; Maximilian A Dambacher; Didier Hans; Florian Hartl; Hansjorg J Häuselmann; Marius Kraenzlin; Kurt Lippuner; Maurus Neff; Pierro Pancaldi; Rene Rizzoli; Franco Tanzi; Robert Theiler; Alan Tyndall; Claus Wimpfheimer; Peter Burckhardt
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

2.  Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  T M Vogt; P D Ross; L Palermo; T Musliner; H K Genant; D Black; D E Thompson
Journal:  Mayo Clin Proc       Date:  2000-09       Impact factor: 7.616

3.  Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria.

Authors:  M L Frost; G M Blake; I Fogelman
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

4.  Comparison of bone mineral density at various skeletal sites with quantitative ultrasound parameters of the calcaneus for assessment of vertebral fractures.

Authors:  Y Hamanaka; I Yamamoto; M Takada; R Matsushita; T Ota; I Yuh; R Morita
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

5.  The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study.

Authors:  M Lunt; P Masaryk; C Scheidt-Nave; J Nijs; G Poor; H Pols; J A Falch; G Hammermeister; D M Reid; L Benevolenskaya; K Weber; J Cannata; T W O'Neill; D Felsenberg; A J Silman; J Reeve
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

6.  Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.

Authors:  R Hasserius; M K Karlsson; B E Nilsson; I Redlund-Johnell; O Johnell
Journal:  Osteoporos Int       Date:  2003-01       Impact factor: 4.507

7.  Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study.

Authors:  Steven Boonen; Jos Nijs; Herman Borghs; Herman Peeters; Dirk Vanderschueren; Frank P Luyten
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

Review 8.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

9.  Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study.

Authors:  Claus C Glüer; Richard Eastell; David M Reid; Dieter Felsenberg; Christian Roux; Reinhard Barkmann; Wolfram Timm; Tilo Blenk; Gabi Armbrecht; Alison Stewart; Jackie Clowes; Friederike E Thomasius; Sami Kolta
Journal:  J Bone Miner Res       Date:  2004-03-01       Impact factor: 6.741

10.  Determinants of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii.

Authors:  C Huang; P D Ross; S Fujiwara; J W Davis; R S Epstein; K Kodama; R D Wasnich
Journal:  Bone       Date:  1996-05       Impact factor: 4.398

View more
  1 in total

Review 1.  Heel bone mass of a young South Indian population with a Nigerian population residing in a South Indian suburban neighborhood: a comparative study.

Authors:  V Sapthagirivasan; M Anburajan
Journal:  Osteoporos Int       Date:  2012-02-14       Impact factor: 4.507

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.